FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313647525> ?p ?o ?g. }

• W4313647525 endingPage "641.e34" @default.
• W4313647525 startingPage "630" @default.
• W4313647525 abstract "Background & Aims The etiology of abdominal pain in postinfectious, diarrhea-predominant irritable bowel syndrome (PI-IBS-D) is unknown, and few treatment options exist. Catechol-O-methyltransferase (COMT), an enzyme that inactivates and degrades biologically active catecholamines, plays an important role in numerous physiologic processes, including modulation of pain perception. Our objective was to determine the mechanism(s) of how decreased colonic COMT in PI-IBS-D patients contributes to the chronic abdominal pain phenotype after enteric infections. Methods Colon neurons, epithelial cells, and macrophages were procured with laser capture microdissection from PI-IBS-D patients to evaluate cell-specific colonic COMT, microRNA-155 (miR-155), and tumor necrosis factor (TNF) α expression levels compared to recovered patients (infection cleared: did not develop PI-IBS-D) and control individuals. COMT–/–, colon-specific COMT–/–, and miR-155–/– mice and human colonoids were used to model phenotypic expression of COMT in PI-IBS-D patients and to investigate signaling pathways linking abdominal pain. Citrobacter rodentium and trinitrobenzene sulfonic acid animal models were used to model postinflammatory changes seen in PI-IBS-D patients. Results Colonic COMT levels were significantly decreased and correlated with increased visual analog scale abdominal pain ratings in PI-IBS-D patients compared to recovered patients and control individuals. Colonic miR-155 and TNF-α were increased in PI-IBS-D patients with diminished colonic COMT. COMT–/– mice had significantly increased expression of miR-155 and TNF-α in both colon tissues and dorsal root ganglia. Introduction of cV1q antibody (anti-TNF-α) into mice reversed visceral hypersensitivity after C rodentium and trinitrobenzene sulfonic acid. Conclusions Decreased colonic COMT in PI-IBS-D patients drives abdominal pain phenotypes via the COMT/miR-155/TNF-α axis. These important findings will allow new treatment paradigms and more targeted and personalized medicine approaches for gastrointestinal disorders after enteric infections. The etiology of abdominal pain in postinfectious, diarrhea-predominant irritable bowel syndrome (PI-IBS-D) is unknown, and few treatment options exist. Catechol-O-methyltransferase (COMT), an enzyme that inactivates and degrades biologically active catecholamines, plays an important role in numerous physiologic processes, including modulation of pain perception. Our objective was to determine the mechanism(s) of how decreased colonic COMT in PI-IBS-D patients contributes to the chronic abdominal pain phenotype after enteric infections. Colon neurons, epithelial cells, and macrophages were procured with laser capture microdissection from PI-IBS-D patients to evaluate cell-specific colonic COMT, microRNA-155 (miR-155), and tumor necrosis factor (TNF) α expression levels compared to recovered patients (infection cleared: did not develop PI-IBS-D) and control individuals. COMT–/–, colon-specific COMT–/–, and miR-155–/– mice and human colonoids were used to model phenotypic expression of COMT in PI-IBS-D patients and to investigate signaling pathways linking abdominal pain. Citrobacter rodentium and trinitrobenzene sulfonic acid animal models were used to model postinflammatory changes seen in PI-IBS-D patients. Colonic COMT levels were significantly decreased and correlated with increased visual analog scale abdominal pain ratings in PI-IBS-D patients compared to recovered patients and control individuals. Colonic miR-155 and TNF-α were increased in PI-IBS-D patients with diminished colonic COMT. COMT–/– mice had significantly increased expression of miR-155 and TNF-α in both colon tissues and dorsal root ganglia. Introduction of cV1q antibody (anti-TNF-α) into mice reversed visceral hypersensitivity after C rodentium and trinitrobenzene sulfonic acid. Decreased colonic COMT in PI-IBS-D patients drives abdominal pain phenotypes via the COMT/miR-155/TNF-α axis. These important findings will allow new treatment paradigms and more targeted and personalized medicine approaches for gastrointestinal disorders after enteric infections." @default.
• W4313647525 created "2023-01-07" @default.
• W4313647525 creator A5012359057 @default.
• W4313647525 creator A5014175034 @default.
• W4313647525 creator A5026763035 @default.
• W4313647525 creator A5052747073 @default.
• W4313647525 creator A5076889483 @default.
• W4313647525 creator A5086086335 @default.
• W4313647525 date "2023-04-01" @default.
• W4313647525 modified "2023-10-15" @default.
• W4313647525 title "Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor α Axis" @default.
• W4313647525 cites W176087980 @default.
• W4313647525 cites W1988001624 @default.
• W4313647525 cites W1990734154 @default.
• W4313647525 cites W2015358266 @default.
• W4313647525 cites W2016124588 @default.
• W4313647525 cites W2020004405 @default.
• W4313647525 cites W2026748344 @default.
• W4313647525 cites W2035187012 @default.
• W4313647525 cites W2038810061 @default.
• W4313647525 cites W2040493240 @default.
• W4313647525 cites W2044352384 @default.
• W4313647525 cites W2052096219 @default.
• W4313647525 cites W2070691522 @default.
• W4313647525 cites W2086989364 @default.
• W4313647525 cites W2100318829 @default.
• W4313647525 cites W2102662093 @default.
• W4313647525 cites W2105837661 @default.
• W4313647525 cites W2118028558 @default.
• W4313647525 cites W2122244729 @default.
• W4313647525 cites W2122935354 @default.
• W4313647525 cites W2129097062 @default.
• W4313647525 cites W2130177040 @default.
• W4313647525 cites W2146481987 @default.
• W4313647525 cites W2157275283 @default.
• W4313647525 cites W2161789287 @default.
• W4313647525 cites W2166540695 @default.
• W4313647525 cites W2293175887 @default.
• W4313647525 cites W2326800121 @default.
• W4313647525 cites W2399950177 @default.
• W4313647525 cites W2518441479 @default.
• W4313647525 cites W2533066341 @default.
• W4313647525 cites W2747732793 @default.
• W4313647525 cites W2765937717 @default.
• W4313647525 cites W2769660358 @default.
• W4313647525 cites W2888929155 @default.
• W4313647525 cites W3184034537 @default.
• W4313647525 cites W608634786 @default.
• W4313647525 doi "https://doi.org/10.1053/j.gastro.2022.12.041" @default.
• W4313647525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36623778" @default.
• W4313647525 hasPublicationYear "2023" @default.
• W4313647525 type Work @default.
• W4313647525 citedByCount "0" @default.
• W4313647525 crossrefType "journal-article" @default.
• W4313647525 hasAuthorship W4313647525A5012359057 @default.
• W4313647525 hasAuthorship W4313647525A5014175034 @default.
• W4313647525 hasAuthorship W4313647525A5026763035 @default.
• W4313647525 hasAuthorship W4313647525A5052747073 @default.
• W4313647525 hasAuthorship W4313647525A5076889483 @default.
• W4313647525 hasAuthorship W4313647525A5086086335 @default.
• W4313647525 hasConcept C104317684 @default.
• W4313647525 hasConcept C126322002 @default.
• W4313647525 hasConcept C15490471 @default.
• W4313647525 hasConcept C170493617 @default.
• W4313647525 hasConcept C17991360 @default.
• W4313647525 hasConcept C180754005 @default.
• W4313647525 hasConcept C185361966 @default.
• W4313647525 hasConcept C2778271842 @default.
• W4313647525 hasConcept C2779794527 @default.
• W4313647525 hasConcept C55493867 @default.
• W4313647525 hasConcept C71924100 @default.
• W4313647525 hasConcept C86803240 @default.
• W4313647525 hasConcept C90924648 @default.
• W4313647525 hasConceptScore W4313647525C104317684 @default.
• W4313647525 hasConceptScore W4313647525C126322002 @default.
• W4313647525 hasConceptScore W4313647525C15490471 @default.
• W4313647525 hasConceptScore W4313647525C170493617 @default.
• W4313647525 hasConceptScore W4313647525C17991360 @default.
• W4313647525 hasConceptScore W4313647525C180754005 @default.
• W4313647525 hasConceptScore W4313647525C185361966 @default.
• W4313647525 hasConceptScore W4313647525C2778271842 @default.
• W4313647525 hasConceptScore W4313647525C2779794527 @default.
• W4313647525 hasConceptScore W4313647525C55493867 @default.
• W4313647525 hasConceptScore W4313647525C71924100 @default.
• W4313647525 hasConceptScore W4313647525C86803240 @default.
• W4313647525 hasConceptScore W4313647525C90924648 @default.
• W4313647525 hasFunder F4320306127 @default.
• W4313647525 hasFunder F4320332161 @default.
• W4313647525 hasFunder F4320337357 @default.
• W4313647525 hasIssue "4" @default.
• W4313647525 hasLocation W43136475251 @default.
• W4313647525 hasLocation W43136475252 @default.
• W4313647525 hasOpenAccess W4313647525 @default.
• W4313647525 hasPrimaryLocation W43136475251 @default.
• W4313647525 hasRelatedWork W1979377324 @default.
• W4313647525 hasRelatedWork W1989415705 @default.
• W4313647525 hasRelatedWork W2000156804 @default.
• W4313647525 hasRelatedWork W2039274295 @default.

• next